EP3924367A4 - Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis - Google Patents

Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis Download PDF

Info

Publication number: EP3924367A4
Authority: EP; European Patent Office
Prior art keywords: vegf; growth factor; wound healing; vascular endothelial; endothelial growth
Prior art date: 2019-04-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP20908461.5A

Other languages

German (de)

French (fr)

Other versions

EP3924367A2 (en

Inventor

Anoop Kumar Thekkuveettil

Sheeja Liza EASO

Geethu SHAJI

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sree Chitra Tirunal Institute For Medical Sciences And Technology

Original Assignee

Sree Chitra Tirunal Institute For Medical Sciences And Technology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-04-04

Filing date

2020-04-02

Publication date

2022-10-12

2020-04-02 Application filed by Sree Chitra Tirunal Institute For Medical Sciences And Technology filed Critical Sree Chitra Tirunal Institute For Medical Sciences And Technology

2021-12-22 Publication of EP3924367A2 publication Critical patent/EP3924367A2/en

2022-10-12 Publication of EP3924367A4 publication Critical patent/EP3924367A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)

EP20908461.5A 2019-04-04 2020-04-02 Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis Withdrawn EP3924367A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN201941013671		2019-04-04
PCT/IN2020/050321 WO2020202214A2 (en)	2019-04-04	2020-04-02	Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis

Publications (2)

Publication Number	Publication Date
EP3924367A2 EP3924367A2 (en)	2021-12-22
EP3924367A4 true EP3924367A4 (en)	2022-10-12

Family

ID=72667624

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP20908461.5A Withdrawn EP3924367A4 (en)	2019-04-04	2020-04-02	Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis

Country Status (2)

Country	Link
EP (1)	EP3924367A4 (en)
WO (1)	WO2020202214A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7928061B2 (en) *	1996-08-23	2011-04-19	Vegenics Pty Limited	Methods of using VEGF-D polypeptides

2020
- 2020-04-02 EP EP20908461.5A patent/EP3924367A4/en not_active Withdrawn
- 2020-04-02 WO PCT/IN2020/050321 patent/WO2020202214A2/en unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7928061B2 (en) *	1996-08-23	2011-04-19	Vegenics Pty Limited	Methods of using VEGF-D polypeptides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ORLANDINI M ET AL: "IDENTIFICATION OF A C-FOS INDUCED GENE THAT IS RELATED TO THE PLATELET-DERIVED GROWTH FACTOR/VASCULAR ENDOTHELIAL GROWTH FACTOR FAMILY", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 93, no. 21, 15 October 1996 (1996-10-15), pages 11675 - 11680, XP002029340, ISSN: 0027-8424, DOI: 10.1073/PNAS.93.21.11675 *
RISSANEN TUOMAS T ET AL: "VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses", CIRCULATION RESEARCH, AMERICAN HEART ASSOCIATION, INC, US, vol. 92, no. 10, 30 May 2003 (2003-05-30), pages 1098 - 1106, XP002491555, ISSN: 1524-4571, DOI: 10.1161/01.RES.0000073584.46059.E3 *
VEIKKOLA TANJA ET AL: "VEGFs, receptors and angiogenesis", SEMINARS IN CANCER BIOLOGY, SAUNDERS SCIENTIFIC PUBLICATIONS, PHILADELPHIA, PA, US, vol. 9, no. 3, 1 June 1999 (1999-06-01), pages 211 - 220, XP002198307, ISSN: 1044-579X, DOI: 10.1006/SCBI.1998.0091 *
YAMADA Y ET AL: "Molecular Cloning of a Novel Vascular Endothelial Growth Factor, VEGF-D", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 42, no. 3, 15 June 1997 (1997-06-15), pages 483 - 488, XP004459556, ISSN: 0888-7543, DOI: 10.1006/GENO.1997.4774 *

Also Published As

Publication number	Publication date
WO2020202214A2 (en)	2020-10-08
EP3924367A2 (en)	2021-12-22
WO2020202214A4 (en)	2021-03-11
WO2020202214A3 (en)	2020-12-03

Publication	Publication Date	Title
EP3908354A4 (en)	2023-04-26	Filamentary devices for treatment of vascular defects
IL271378A (en)	2020-01-30	Novel wound dressing for haemostasis
EP3846757A4 (en)	2022-06-15	Adaptable adhesive wound dressings
EP3957576A4 (en)	2023-01-25	Film-packed tissue set package
EP4034007A4 (en)	2023-10-18	Balloon basket catheter device
EP3242677A4 (en)	2018-09-26	Therapeutic angiogenesis for wound healing
EP4062869A4 (en)	2024-01-10	Dual-layer lumen stent
EP4021343A4 (en)	2023-10-04	Submucosal bioresorbable drug eluting platform
EP3988157A4 (en)	2022-08-10	Balloon catheter
GB202408972D0 (en)	2024-08-07	Wound dressing
EP3906000A4 (en)	2022-06-22	Re-closable wound dressing
EP3920861A4 (en)	2022-09-07	Enhanced trauma bandage
EP3917462A4 (en)	2023-03-22	Improved stent delivery for vascular surgery
EP3924367A4 (en)	2022-10-12	Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis
EP4084834A4 (en)	2024-01-03	Smart wound dressings
EP4038767A4 (en)	2023-12-06	Frequency control
EP3944733A4 (en)	2023-01-25	Suture package
PL3739149T3 (en)	2022-05-23	Automatic winder
DK3838238T3 (en)	2023-05-01	DOUBLE COATING FOR WOUND DRESSINGS
EP3970782A4 (en)	2022-07-06	Balloon catheter
GB201812812D0 (en)	2018-09-19	Disposable wound dressings
EP4048197A4 (en)	2023-11-29	Absorbable vascular filter
EP3922252A4 (en)	2022-11-16	Composition for enhancing vascular endothelial function
EP4043626A4 (en)	2023-11-22	Thread
EP4025738A4 (en)	2023-08-30	Fluff pulp

Legal Events

Date	Code	Title	Description
2021-07-10	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: UNKNOWN
2021-07-27	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2021-11-19	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2021-11-19	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2021-12-22	17P	Request for examination filed	Effective date: 20210804
2021-12-22	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2022-07-13	DAV	Request for validation of the european patent (deleted)
2022-07-13	DAX	Request for extension of the european patent (deleted)
2022-10-12	A4	Supplementary search report drawn up and despatched	Effective date: 20220909
2022-10-12	RIC1	Information provided on ipc code assigned before grant	Ipc: C12N 15/11 20060101ALI20220905BHEP Ipc: A61K 39/00 20060101ALI20220905BHEP Ipc: C07K 14/515 20060101AFI20220905BHEP
2023-08-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2023-09-27	18D	Application deemed to be withdrawn	Effective date: 20230412